Technology from medical-device manufacturer Sanarus Technologies LLC makes benign breast tumors disappear without surgery. The Visica 2 Treatment System uses cryoablation—a technique for eradicating diseased tissue with extreme cold—to target fibroadenomas, a noncancerous (i.e., benign) breast tumor consisting of glandular and fibrous tissue.
To prototype, design, and ultimately deploy this innovative product, designers of the Visica 2 used National Instruments’ CompactRIO embedded system (which includes a Xilinx® FPGA).